SecBot SecBot
Insider Cluster (3 insiders) ·Filed Aug 5, 2026

NRIX

Nurix Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 3 insiders, $0.5M total
Actionable Insight • Neutral

No material signal from this insider cluster. The small dollar amounts and pattern of option exercises followed by sales suggest routine liquidity management. Monitor for upcoming clinical catalysts or partnership announcements as the primary drivers for NRIX.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$25.12
T+0 close · Aug 5, 2026 · via day close
Latest settled
+6.01%
T+5 · $26.63
Vs SPY
+5.66%
α at T+5
Next horizon
T+20
due 3mo ago
  1. T+0 · Aug 5 $25.12entry
  2. T+1 · 3mo ago +0.40%α +0.56% · $25.22
  3. T+5 · 3mo ago +6.01%α +5.66% · $26.63
  4. T+20 · due 3mo ago Pending
  5. T+60 · due 19d ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three C-suite insiders at Nurix Therapeutics (CSO, CLO, CFO) sold a total of $461K in open-market shares over a 7-day window, representing just 0.02% of the $2.4B market cap. The sales are trivial in size and appear liquidity-driven following option exercises, providing no material signal about the company's outlook.

Key Financial Metrics

Direction
selling
Total Value
$461.0K
Insiders
3

Key Facts

  • Total open-market insider sales: $461,000 across 3 C-suite executives (CSO, CLO, CFO)
  • Sales represent 0.02% of Nurix's $2.4B market cap, well below the 0.1% materiality threshold
  • Multiple derivative exercises (non-cash) preceded the sales, consistent with routine option exercise and tax-covering or diversification
  • Prior insider activity (30d) shows 6 sells totaling $665K, indicating ongoing but modest selling patterns

Financial Impact

Trivial insider sales totaling $461K, representing 0.02% of market cap.

insider sellingdilution from option exercises

Risk Factors

  • None from this filing, insider activity is immaterial in size and context

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NRIX-1785927676296

Track record

33 reports on NRIX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +53.71% at T+20 after the Jun 8, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.17 Now $15.48 +2.04% settles Dec 15
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.41 Now $15.48 +0.45% settles Dec 15
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $14.84 Now $15.48 +4.31% settles Dec 4
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $14.84 Now $15.48 +4.31% settles Dec 4
  6. Nov 4, 202612d ago 144 Neutral 2/10 Entry $14.84 Now $15.48 +4.31% settles Dec 4
  7. Nov 3, 202613d ago 144 Neutral 2/10 Entry $15.95 Now $15.48 −2.95% settles Dec 3
  8. Nov 3, 202613d ago 8-K Bearish 5/10 Entry $15.95 Now $15.48 +2.95% settles Dec 3
  9. Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $25.82 Now $15.48 −40.05% settles Dec 2
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $25.82 Now $15.48 −40.05% settles Dec 2
Showing 10 of 33

US Market Status

Market Closed · Opens Wed (11h 58m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 5, 2026